Shanghai Realbio Technology (RBT) Co., Ltd.,

Shanghai Realbio Technology (RBT) Co., Ltd., was established in 2014 and is headquartered in Shanghai Pujiang High-tech Park. It has established regional centers in Hangzhou, Qingdao, Beijing, Wuhan and other places. It is a national high-tech enterprise specializing in genetic technology and health services. The company has always been adhering to the corporate philosophy of "forge ahead", relying on strong technical strength, adhering to the mission of letting everyone enjoy a healthy life, creating beauty for health, creating miracles for life, and fulfilling the vision of human beings. Customers provide the highest quality products and services.
Since its establishment, the company has established a high-quality comprehensive team from top universities at home and abroad, multidisciplinary and interdisciplinary, including many elites in genomics, medicine, bioinformatics and other fields, of which more than 60% have a master's degree or above. Relying on the high-throughput sequencing technology platform, the company focuses on the breakthroughs in basic scientific research in the cutting-edge technology and research results of the human microbiome, as well as the transformation and application in medicine. It has obtained more than 40 software copyrights and multiple patents. The team members have been Many articles have been published in international journals such as Nature, Science and Nature Genetics. Develop detection technologies and application solutions in precision medical fields such as early screening and diagnosis of colorectal cancer, and metagenomic detection of infectious microorganisms. It is committed to providing early disease detection and comprehensive health management services for medical institutions. It has reached depth with more than 300 top hospitals across the country. Cooperation.
The company has successively won many honorary titles such as "National High-tech Enterprise", "Shanghai Specialized and Special New Small and Medium-sized Enterprise", "Shanghai Minhang Top Ten Technology Entrepreneurship Enterprise", "Shanghai Top 50 Venture Enterprise with Most Investment Potential". Up to now, the company has successfully obtained four rounds of investment from well-known investment companies such as Lucion Venture Capital, Zhangjiang Hi-Tech, Marathon Venture Partners, Songhe Capital, etc. The cumulative financing amount has exceeded 200 million yuan.

Hangzhou Realgene Technology Co., Ltd.

Hangzhou Realgene Technology Co., Ltd. is located in the West Lake Science and Technology Park in Hangzhou City, Zhejiang Province. It is the R&D center of Realbio Technology Group. The company has domestic advanced supporting experimental equipment and a powerful biological information analysis platform, complete laboratory equipment, including MiniSeq sequencer, interrupter Biorupter, detection equipment Agilent2100, Qubit2.0 fluorometer, PCR instrument, electrophoresis, centrifuge, Gel imaging equipment, etc. In terms of information analysis platform construction, the company has a computer cluster suitable for massive biological information analysis, 20 computing nodes with 64G memory, 3 computing nodes with 1T large memory, 10 sets of high-performance storage, with a total storage space of 1.2PB, data center The computing power has reached 50T flops, and the node CPUs are all Intel Xeon series. The center is also equipped with a 10-Gigabit high-speed switching network, UPS uninterruptible power supply, etc. to ensure the normal and stable operation of the computing cluster.

Qingdao Realbio Precision Medical Laboratory Co., Ltd.,

Qingdao Realbio Precision Medical Laboratory Co., Ltd., was registered in November 2017 and is located in the Qingdao International Economic Cooperation Zone (Sino-German Ecological Park) of Shandong Free Trade Zone. Qingdao Realbio Precision Medical Testing Center is a North China inspection service headquarters base carefully built by Realbio Technology Group. It has a medical institution license and the service scope covers the entire North China region. A medical inspection office with a technical review certificate for clinical gene amplification testing laboratories. In mid-February 2020, it passed the Inter-laboratory Quality Assessment of New Coronavirus Nucleic Acid Test by Shanghai Clinical Laboratory Center (CNAS PT0025) and Shanghai Clinical Laboratory Quality Control Center with a perfect score.

版权所有 上海锐翌生物科技有限公司 沪ICP备16022951号